BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35470979)

  • 1. High Prevalence but Low Impact of Cognitive Dysfunction on Quality of Life in Patients With Lupus and Neuropsychiatric Symptoms.
    Monahan RC; Middelkoop HAM; Beaart-van de Voorde LJJ; Fronczek R; Groenwold RHH; Kloppenburg M; Huizinga TWJ; Steup-Beekman GM
    Arthritis Care Res (Hoboken); 2023 May; 75(5):1017-1025. PubMed ID: 35470979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptoms.
    Monahan RC; Inglese F; Middelkoop H; van Buchem M; Huizinga TW; Kloppenburg M; Ronen I; Steup-Beekman GM; de Bresser J
    RMD Open; 2021 Jul; 7(2):. PubMed ID: 34321253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric symptoms in systemic lupus erythematosus: impact on quality of life.
    Monahan RC; Beaart-van de Voorde LJJ; Steup-Beekman GM; Magro-Checa C; Huizinga TWJ; Hoekman J; Kaptein AA
    Lupus; 2017 Oct; 26(12):1252-1259. PubMed ID: 28420059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity.
    Monahan RC; Beaart-van de Voorde LJ; Eikenboom J; Fronczek R; Kloppenburg M; Middelkoop HA; Terwindt GM; van der Wee NJ; Huizinga TW; Steup-Beekman GM
    Lupus; 2021 Jun; 30(7):1124-1132. PubMed ID: 33779389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach.
    Hanly JG; Urowitz MB; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Clarke AE; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; Alarcón GS; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian KC; Jacobsen S; Peschken CA; Kamen DL; Askanase A; Farewell V
    Ann Rheum Dis; 2020 Mar; 79(3):356-362. PubMed ID: 31915121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus.
    Calderón J; Flores P; Aguirre JM; Valdivia G; Padilla O; Barra I; Scoriels L; Herrera S; González A; Massardo L
    Scand J Rheumatol; 2017 Jul; 46(4):273-280. PubMed ID: 27701937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Hanly JG; Fisk JD; McCurdy G; Fougere L; Douglas JA
    J Rheumatol; 2005 Aug; 32(8):1459-6. PubMed ID: 16078320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study.
    Ceccarelli F; Pirone C; Mina C; Mascolo A; Perricone C; Massaro L; Spinelli FR; Alessandri C; Valesini G; Conti F
    PLoS One; 2019; 14(11):e0224437. PubMed ID: 31682630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis.
    Zabala A; Salgueiro M; Sáez-Atxukarro O; Ballesteros J; Ruiz-Irastorza G; Segarra R
    J Int Neuropsychol Soc; 2018 Jul; 24(6):629-639. PubMed ID: 29553037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.
    Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA
    Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric manifestations are not uncommon in Indian lupus patients and negatively affect quality of life.
    Muhammed H; Goyal M; Lal V; Singh S; Dhir V
    Lupus; 2018 Apr; 27(4):688-693. PubMed ID: 29241417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of neuropsychiatric events in systemic lupus erythematosus.
    Hanly JG; Su L; Farewell V; McCurdy G; Fougere L; Thompson K
    J Rheumatol; 2009 Jul; 36(7):1449-59. PubMed ID: 19447937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus patients with past neuropsychiatric involvement are associated with worse cognitive impairment: a longitudinal study.
    Gao Y; Lau EY; Wan JH; Lau CS; Mok MY
    Lupus; 2016 May; 25(6):637-44. PubMed ID: 26700182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with neuropsychiatric involvement systemic lupus erythematosus experience poorer health-related quality of life and more fatigue than systemic lupus erythematosus patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity.
    Nikolopoulos D; Cetrez N; Lindblom J; Palazzo L; Enman Y; Parodis I
    Rheumatology (Oxford); 2024 Apr; ():. PubMed ID: 38579198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive performance in systemic lupus erythematosus patients: a cross-sectional and longitudinal study.
    Langensee L; Mårtensson J; Jönsen A; Zervides K; Bengtsson A; Nystedt J; Cannerfelt B; Nilsson P; Mannfolk P; Lätt J; Rumetshofer T; Sundgren PC
    BMC Rheumatol; 2022 Apr; 6(1):22. PubMed ID: 35440096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
    Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
    Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different phenotypes of neuropsychiatric systemic lupus erythematosus are related to a distinct pattern of structural changes on brain MRI.
    Inglese F; Kant IMJ; Monahan RC; Steup-Beekman GM; Huizinga TWJ; van Buchem MA; Magro-Checa C; Ronen I; de Bresser J
    Eur Radiol; 2021 Nov; 31(11):8208-8217. PubMed ID: 33929569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
    Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P
    Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
    Wang M; Gladman DD; Ibañez D; Urowitz MB
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus.
    Zervides KA; Janelidze S; Nystedt J; Gullstrand B; Nilsson P; Sundgren PC; Bengtsson AA; Hansson O; Jönsen A
    BMC Neurol; 2022 Dec; 22(1):467. PubMed ID: 36494778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.